Literature DB >> 3228283

Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory.

R W Foltin1, M W Fischman, M F Byrne.   

Abstract

Six adult male research volunteers, in two groups of three subjects each, lived in a residential laboratory for 13 days. All contact with the experimenter was through a networked computer system and subjects' behaviors, including food intake, were continuously recorded. During the first part of the day, subjects remained in continuously recorded. During the first part of the day, subjects remained in their private rooms doing planned work activities, and during the remainder of the day, they were allowed to socialize. Two cigarettes containing active marijuana (2.3% delta 9 THC) or placebo were smoked during both the private work period and the period of access to social activities. Smoked active marijuana significantly increased total daily caloric intake by 40%. Increased food intake was evident during both private and social periods. The increase in caloric intake was due to an increased consumption of snack foods as a consequence of an increase in the number of snacking occasions. There was no significant change in caloric consumption during meals. The principal increase within the category of snack foods was in the intake of sweet solid items, e.g., candy bars, compared to sweet fluid, e.g., soda, or savory solid items, e.g., potato chips. Increases in body weight during periods of active marijuana smoking were greater than predicted by caloric intake alone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3228283     DOI: 10.1016/s0195-6663(88)80017-5

Source DB:  PubMed          Journal:  Appetite        ISSN: 0195-6663            Impact factor:   3.868


  65 in total

Review 1.  Neuroendocrine regulation of eating behavior.

Authors:  R Vettor; R Fabris; C Pagano; G Federspil
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

Review 2.  The behavioral pharmacology of anorexigenic drugs in nonhuman primates: 30 years of progress.

Authors:  Richard W Foltin
Journal:  Behav Pharmacol       Date:  2012-09       Impact factor: 2.293

3.  Does co-morbid depression alter the inverse relationship between obesity and substance use disorders?

Authors:  Ashley N Gearhardt; Emily L R Harrison; Sherry A McKee
Journal:  Drug Alcohol Depend       Date:  2012-01-28       Impact factor: 4.492

4.  The endocannabinoid system modulates the valence of the emotion associated to food ingestion.

Authors:  Mónica Méndez-Díaz; Pavel Ernesto Rueda-Orozco; Alejandra Evelyn Ruiz-Contreras; Oscar Prospéro-García
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

5.  Cannabinoid facilitation of behavioral and biochemical hedonic taste responses.

Authors:  M A De Luca; M Solinas; Z Bimpisidis; S R Goldberg; G Di Chiara
Journal:  Neuropharmacology       Date:  2011-11-02       Impact factor: 5.250

Review 6.  Current and novel approaches to the drug therapy of obesity.

Authors:  Jean-Philippe Chaput; Angelo Tremblay
Journal:  Eur J Clin Pharmacol       Date:  2006-08-26       Impact factor: 2.953

Review 7.  Managing cancer-related anorexia/cachexia.

Authors:  G Mantovani; A Macciò; E Massa; C Madeddu
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 8.  Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions.

Authors:  John D Salamone; Peter J McLaughlin; Kelly Sink; Alexandros Makriyannis; Linda A Parker
Journal:  Physiol Behav       Date:  2007-04-14

9.  Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance.

Authors:  L D Chait; J L Perry
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

10.  Associations between body mass index and substance use disorders differ by gender: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Danielle Barry; Nancy M Petry
Journal:  Addict Behav       Date:  2008-08-27       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.